Recent reports have shown that the neutralization of IL-17 using IL-17 receptor Ad:FC downregulates the expression of IL-6, tumor necrosis factor, etc., in colitis induced by trinitro-benzene-sulfonic acid [12], in atherosclerosis [13] and in concanavalin A-induced hepatitis [14]. The gene discussed is IL17A; the disease is colitis.